Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
FPH | Ann: Capital Change Notice - North America ESPP | 02/10/24 | 0 | 32 | |||
|
|||||||
FPH | Ann: Ongoing Disclosure Notice - Ordinary Shares | 02/10/24 | 0 | 36 | |||
|
|||||||
FPH | Ann: Initial Disclosure Notice - Ordinary Shares | 01/10/24 | 0 | 31 | |||
|
|||||||
FPH | Ann: Ongoing Disclosure Notice - Ordinary Shares | 26/09/24 | 0 | 29 | |||
|
|||||||
FPH | Ann: SPH Notice - Mitsubishi UFJ Financial Group | 25/09/24 | 0 | 66 | |||
|
|||||||
FPH | Ann: Ongoing Disclosure Notice - Ordinary Shares | 24/09/24 | 0 | 30 | |||
|
|||||||
FPH | Ann: Ongoing Disclosure Notice - Ordinary Shares | 24/09/24 | 0 | 30 | |||
|
|||||||
FPH | Ann: Ongoing Disclosure Notice - Ordinary Shares | 23/09/24 | 0 | 29 | |||
|
See All Discussions